EUVIMEDEUVIMED entdecken
Crossref

Urinary peptidome analysis of kidney failure in children with obstructive uropathy

Bénédicte Buffin-Meyer, Babacar Sylla, Kleanthi Voutsadaki, Julie Klein, Justyna Siwy, Thi Minh Nghia Nguyen, Benjamin Breuil, Eléonore Delecroix, Sheila Murunga, Franz Schaefer, Kathrin Burgmaier, Max C Liebau und 5 weitere

Pediatric Nephrology · 03.11.2026

DOI: 10.1007/s00467-026-07574-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, online erschienen am 03.11.2026. Verfasst von Bénédicte Buffin-Meyer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, I2MC, Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, Toulouse, France. Die Arbeit nennt 31 Literaturangaben. Gefördert von: NIDDK NIH HHS, NIH HHS, HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children with congenital obstructive uropathy (OU) who survive infancy are at increased risk for progressive chronic kidney disease (CKD), but disease onset and severity vary widely, highlighting the need for improved risk stratification. The present study evaluated whether urinary peptidome analysis could predict progression to kidney failure (KF) in children with OU.

Methods

Urinary peptidome analysis was performed on 151 samples from children with OU enrolled in the Chronic Kidney Disease in Children (CKiD) Study. Progression to KF was defined as a ≥50% decline in estimated glomerular filtration rate or initiation of kidney replacement therapy. Peptides were incorporated into a random survival forest model developed in a training cohort and tested in an independent validation cohort. Performance was compared to the 5-year Kidney Failure Risk Equation (KFRE).

Results

Over a median follow-up of 5.6 years, 33% (50/151) of children progressed to KF. Iterative cross-validation identified 47 urinary peptides predictive of KF within 5 years in the training set of 101 patients. The model achieved an area under the curve of 88.6% (95% CI: 75.2–97.8), with sensitivity of 66.7% and specificity of 88.0% in the validation cohort of 50 patients, demonstrating similar overall performance, but higher specificity and lower sensitivity, than the KFRE. Independent and external validation in 162 patients with CKD other than OU confirmed the performance of the peptide model.

Conclusions

Urinary peptidomics identifies children with mild to moderate OU-related CKD at risk for KF with high specificity and moderate sensitivity. Although overall performance was comparable to the KFRE, the peptide model’s specificity may be particularly useful for stratifying patients at intermediate KFRE risk. Abstract Graphical A higher resolution version of the Graphical abstract is available as Supplementary information

Schlagwörter

Stichwörter der Autor:innen

Congenital obstructive uropathyKidney failurePediatric chronic kidney diseaseUrinary peptidomicsUrine biomarkers

Autor:innen und Institutionen

  • Inserm, I2MC, Institut des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, Toulouse, France.
  • Université de Toulouse, Toulouse, France.
  • Mosaiques Diagnostics, Hannover, Germany.
  • Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Heidelberg University, Heidelberg, Germany.
  • Department of Pediatrics, Faculty of Medicine, University Hospital Cologne and University of Cologne, Cologne, Germany.
  • Faculty of Applied Healthcare Science, Deggendorf Institute of Technology, Deggendorf, Germany.

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • BMBF
  • HORIZON EUROPE Framework Programme
  • Bundesministerium für Bildung und Forschung
  • Marga und Walter Boll-Stiftung
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Buffin-Meyer, B., Sylla, B., Voutsadaki, K., Klein, J., Siwy, J., Nguyen, T. M. N., Breuil, B., Delecroix, E., Murunga, S., Schaefer, F., Burgmaier, K., Liebau, M. C., Boeckhaus, J., Gross, O., McLeod, D. J., Becknell, B., & Schanstra, J. P. (2026). Urinary peptidome analysis of kidney failure in children with obstructive uropathy. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07574-2

Vancouver

Buffin-Meyer B, Sylla B, Voutsadaki K, Klein J, Siwy J, Nguyen TMN, et al. Urinary peptidome analysis of kidney failure in children with obstructive uropathy. Pediatric Nephrology. 2026. doi:10.1007/s00467-026-07574-2

BibTeX
@article{BuffinMeyer2026,
  author = {Buffin-Meyer, Bénédicte and Sylla, Babacar and Voutsadaki, Kleanthi and Klein, Julie and Siwy, Justyna and Nguyen, Thi Minh Nghia and Breuil, Benjamin and Delecroix, Eléonore and Murunga, Sheila and Schaefer, Franz and Burgmaier, Kathrin and Liebau, Max C and Boeckhaus, Jan and Gross, Oliver and McLeod, Daryl J and Becknell, Brian and Schanstra, Joost P},
  title = {Urinary peptidome analysis of kidney failure in children with obstructive uropathy},
  journal = {Pediatric Nephrology},
  year = {2026},
  doi = {10.1007/s00467-026-07574-2}
}
Kostenlos starten →